Oct 07
Abigail, who has Type 1 diabetes, talks about her diagnosis and how diabetes changed her life. To watch more of Abigail’s videos or to watch from our thousands of health related videos, visit http://www.icyou.com
Duration : 0:3:33
Oct 07
Abigail, who has Type 1 diabetes, talks about her diagnosis and how diabetes changed her life. To watch more of Abigail’s videos or to watch from our thousands of health related videos, visit http://www.icyou.com
Duration : 0:3:33
Sep 15
Hill & Valley Bakery teams up with the ADA to help raise awareness about diabetes.
Duration : 0:2:32
Sep 13
Diabetes Diagnosis from Diabetes Care Club. We offer information about Diabetes Diagnosis including Diabetes testing supplies take a step forward to Diabetes Self Management. Visit http://www.DiabetesCareClub.com today or call 800-840-7711 for more information about Diabetes Diagnosis. diabetes, mellitus, autoimmune disease, blindness, blood, glucose, sugar, diabetic
Duration : 0:1:4
Sep 11
We offer information about Diabetes Diagnosis including Diabetes testing supplies take a step forward to Diabetes Self Management. Visit http://diabetescareclub.com/lsm/diabetes-diagnosis.php today or call 800-591-7575 for more information about Diabetes Diagnosis. diabetes, mellitus, autoimmune disease, blindness, blood, glucose, sugar, diabetic
Duration : 0:2:11
Sep 07
http://pcp.onlinemindanao.com
Type 2 diabetes mellitus today is a global epidemic, a continuing challenge despite the availability of effective therapeutic agents. Current treatment guidelines emphasize early and aggressive treatment targetting the known pathophysiological defects in type 2 diabetes. Yet the reality in clinical practice shows that fewer than 50% of patients under treatment achieve HbA1c levels even in developed countries.
More recently, the addition of incretin-based therapy offers significant solutions to the progressive loss of pancreatic beta cell function and other unmet needs in effective diabetes management. In this session, the role of diminished incretin effects in the metabolic derangements in type 2 diabetes will be reviewed. The mechanism of actions and the therapeutic uses of both incretin enhancers and incretin mimetics will be discussed, highlighting efficacy and safety data since they have been available for use in clinical practice. The role of these agents in addressing earliest defects in glucose homeostasis and postprandial hyperglycemia implies potential of preservation of beta cell function. Incretin-based therapy should clearly be considered as a major part of effective diabetes management in current clinical practice.
Duration : 0:7:21
Sep 01
http://www.pcp.onlinemindanao.com
http://www.PhilippinesDailyPhotos.com
http://www.JourneyPhilippines.net
http://www.CagayandeOroBlog.com
Type 2 diabetes mellitus today is a global epidemic, a continuing challenge despite the availability of effective therapeutic agents. Current treatment guidelines emphasize early and aggressive treatment targetting the known pathophysiological defects in type 2 diabetes. Yet the reality in clinical practice shows that fewer than 50% of patients under treatment achieve HbA1c levels even in developed countries.
More recently, the addition of incretin-based therapy offers significant solutions to the progressive loss of pancreatic beta cell function and other unmet needs in effective diabetes management. In this session, the role of diminished incretin effects in the metabolic derangements in type 2 diabetes will be reviewed. The mechanism of actions and the therapeutic uses of both incretin enhancers and incretin mimetics will be discussed, highlighting efficacy and safety data since they have been available for use in clinical practice. The role of these agents in addressing earliest defects in glucose homeostasis and postprandial hyperglycemia implies potential of preservation of beta cell function. Incretin-based therapy should clearly be considered as a major part of effective diabetes management in current clinical practice.
Duration : 0:6:45
Aug 30
http://pcp.onlinemindanao.com
Type 2 diabetes mellitus today is a global epidemic, a continuing challenge despite the availability of effective therapeutic agents. Current treatment guidelines emphasize early and aggressive treatment targetting the known pathophysiological defects in type 2 diabetes. Yet the reality in clinical practice shows that fewer than 50% of patients under treatment achieve HbA1c levels even in developed countries.
More recently, the addition of incretin-based therapy offers significant solutions to the progressive loss of pancreatic beta cell function and other unmet needs in effective diabetes management. In this session, the role of diminished incretin effects in the metabolic derangements in type 2 diabetes will be reviewed. The mechanism of actions and the therapeutic uses of both incretin enhancers and incretin mimetics will be discussed, highlighting efficacy and safety data since they have been available for use in clinical practice. The role of these agents in addressing earliest defects in glucose homeostasis and postprandial hyperglycemia implies potential of preservation of beta cell function. Incretin-based therapy should clearly be considered as a major part of effective diabetes management in current clinical practice.
Duration : 0:7:11
May 20
One-third of diabetics don’t know that they have the condition. How can you avoid being one of them? Check out this video!Watch More Health Videos at Health Guru: http://www.healthguru.com/?YT
Duration : 0:2:55
